The current institutional shareholding score of Theravance Biopharma Inc is 10.00, ranking 1 out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 103.22%, representing a quarter-over-quarter increase of 4.82%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.25% of shares outstanding, with 0.77% increase in holdings.